prescription opioids

Delaware's Prescription Opioid Settlement Distribution Commission says another grant recipient could be sent to the DOJ for investigation, which would mark the second referral of an opioid abatement grant recipient.

Delaware's Office of Auditor of Accounts (AOA) releases the second wave of opioid grantee audits, finding financial inconsistencies within Congo Legacy Center's plans to fund the Congo Tarir Project.

Almost a year after freezing funding due to fraud concerts, Delaware approves nearly $14 million in opioid abatement grants.

After opioid settlement recipient Code Purple was flagged for misusing grant funds in June, the Prescription Opioid Settlement Distribution Commission decided to put all funding on hold until grant distribution procedures could be reviewed.

Delaware’s Prescription Opioid Settlement Fund continues to grow, but distribution of those funds will likely not resume until next year.

After months of anticipation, outside consulting agency Social Contract delivers its recommendations to the Prescription Opioid Settlement Distribution Commission on how it can better allocate funding.

Delaware’s opioid use continues to trend downward, but concerns around youth vaping and marijuana and alcohol use are on the rise.

An external report examining the Prescription Opioid Settlement Distribution Commission’s grant process is expected in October following fraud concerns.

Opioid settlement grant recipients await delayed funding amid mass audits and outside consultancy evaluations.

The governing body of the Prescription Opioid Settlement Distribution Commission is working to revamp its internal controls and grant distribution guidelines following a run-in with fraud concerns.